Podcasts about biomed

Sponsor Section

Access the PHS Digital Coursebook here.Click here to see all of the Project Lead The Way course offerings at PHSVideo about Biomed ProgramTech Ed and Engineering Program videoMath and Computer Science and Cyber Security PLTW classes video 

In this episode, Vera spoke with Ann Beliën, PhD, founder and CEO of Rejuvenate Biomed, a biotech company leveraging AI-driven platforms to develop therapies for age-related diseases and promote healthy aging. Rejuvenate Biomed is aiming to transform the treatment landscape for diseases such as sarcopenia, neuromuscular, metabolic and neurodegenerative disorders. Dr. Beliën founded Rejuvenate Biomed in 2017 and under her leadership, it transitioned from a discovery start-up to a clinical-stage biotech company. Dr. Beliën has more than two decades of experience in drug development that has included international assignments in the US, the Netherlands and Belgium in various therapeutic areas, including oncology, neurology, immunology and infectious diseases. Prior to founding Rejuvenate Biomed, Dr. Beliën served as a due diligence representative for R&D at Johnson & Johnson (J&J) where she was also a member of the management board of Janssen Prevention Center for five years. Dr. Beliën holds a PhD from the University of Irchel in Zürich, Switzerland and a master's degree from the Free University of Brussels (VUB), Belgium. To hear more about how Rejuvenate Biomed is pioneering therapies for age-related diseases and working to promote healthy aging. For more life science and medical device content, visit the Xtalks Vitals homepage. https://xtalks.com/vitals/ Follow Us on Social Media Twitter: https://twitter.com/Xtalks Instagram: https://www.instagram.com/xtalks/ Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured

From medicine to recruitment, property, and finally, the wild world of entrepreneurship... My journey has been anything but a straight line. And what better way to unpack it all than on a podcast with my good friend Sandi?We explored the winding road that led me to where I am today, including a deep dive into my obsession with productivity (essential for juggling all those passions!), how to stay focused while battling ADHD, and why understanding your own quirks is essential for success. But don't worry, it's not all serious talk! Get ready for some laughs, personal anecdotes, and maybe even a few embarrassing childhood stories. If you've ever wanted to learn more about the real me (and steal a few productivity hacks along the way), this episode is a must-listen! Hosted on Acast. See acast.com/privacy for more information.

Hour 3 - Steve and Ted wrap up a Thursday with business news from The Wichita Business Journal.

When a critical device fails mid-surgery, there's only one team to call… Biomed! This week, we're joined by the Bearded Biomed himself, Chace Torres, as he reveals why keeping ORs running smoothly takes more than just maintaining equipment - it requires quick thinking, technical expertise, and partnerships that span all surgical teams. From preventive maintenance to emergency repairs, discover how biomed professionals are driving patient safety and surgical success by ensuring every device is ready when it's needed most. Ready to see surgery through the eyes of healthcare's tech experts? It all comes together in this can't-miss Season 27 finale – tune in here! Season 27 of Beyond Clean releases under the 1 Episode = 1 CE delivery model. After finishing this interview, earn your 1 CE credit immediately by passing the short quiz linked below each week. Visit our CE Credit Hub at https://www.beyondcleanmedia.com/ce-credit-hub to access this quiz and over 350 other free CE credits.  #BeyondClean #SterileProcessing #Podcast #Season27 #PlanetSurgery #Biomed #PreventiveMaintenance

Perkembangan motorik merupakan bagian penting dalam tahap tumbuh kembang anak. Apabila perkembangannya baik, si Kecil pun bisa bermain dan belajar dengan baik seperti anak-anak lainnya. Lalu, bagaimana jika si Kecil mengalami masalah perkembangan motorik? Supaya ketemu solusinya, yuk, konsultasi dengan dokter spesialis anak Mitra Keluarga Pondok Tjandra, dr. Zenia Angelina, SpA., M.Biomed., CBS di Konter Sehat! #kontersehat #MitraKeluarga #MitraKeluargaPondokTjandra #kesehatananak #perkembanganmotorik #motorikkasar #motorikhalus

A recent study in the journal Nature unveiled new proteins that can neutralize the deadliest of snake venoms. They're “new” in that they aren't found in nature—they were created in a lab, dreamed up by AI.Using AI to discover, or design, the building blocks of drugs is a fast-growing area of research. Another team of scientists out of Philadelphia is using AI to discover new antibiotics by resurrecting long-lost molecules from extinct species like neanderthals and woolly mammoths.We know what you're thinking: It sounds too sci-fi to be true.Flora Lichtman talks with two pioneers in the field about how AI is supercharging drug discovery: Dr. César de la Fuente, bioengineer and presidential associate professor at the University of Pennsylvania in Philadelphia, and Nobel laureate Dr. David Baker, director of the Institute for Protein Design and professor at the University of Washington in Seattle.Transcripts for each segment will be available after the show airs on sciencefriday.com.For our Los Angeles listeners: We're working on a story about the toxins left behind by the fires and we want to hear from you. How is this affecting you? Are you worried about the air and water and soil? How are you approaching clean-up? And what questions do you have?Leave us a voicemail at 1-646-767-6532 or send us an email at scifri@sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

C'est avec plaisir que Sim Moove reçoit dans cet épisode un Français ayant plus de 20 ans d'expérience en matière d'enseignement et de recherche notamment en simulation. Très impliqué dans la communauté internationale en simulation, il a publié de nombreux ouvrages et est régulièrement invité à participer à des conférences internationales. Il a contribué au développement de plusieurs centres de simulation (Angleterre, Qatar), de conférences (SESAM, SSH, INACSL) dans de nombreux pays. Vous verrez comment un profil ingénieur biomédical peut tirer son épingle du jeu dans le monde de la simulation avec un très haut niveau d'expertise. Nous avons bien entendu parlé du livre référence “Le débriefing clef en main” publié en 2019 et dont la version 2 est en cours de finition co-écrit avec le Pr Denis Oriot. Pour toute information complémentaire sur notre invité du jour vous pouvez consulter son profil Linkedin, et ses “impressionnantes” contributions scientifiques sur son lien Google Scholar

What happens when the companies holding your most sensitive data start to falter? Sarah is joined by Drex to dive into the alarming challenges facing 23andMe and Atlas Biomed, two major players in genetic testing. Explore the intersection of data privacy, financial instability, and the unique risks of DNA testing. From data breaches to the ethical implications for health systems, this episode uncovers why the stakes are higher than ever for healthcare leaders. Subscribe: This Week HealthTwitter: This Week HealthLinkedIn: Week HealthDonate: Alex's Lemonade Stand: Foundation for Childhood Cancer

Drex delves into the challenges facing companies like 23andMe and Atlas Biomed, highlighting critical concerns around DNA data privacy and the impact of financial struggles on sensitive information. Learn actionable insights to tighten your organization's data agreements, ensure privacy compliance, and mitigate risks in the evolving cybersecurity landscape.Remember, Stay a Little Paranoid Subscribe: This Week HealthTwitter: This Week Health LinkedIn: Week HealthDonate: Alex's Lemonade Stand: Foundation for Childhood Cancer

Welcome back to another episode of Science of Slink! Today we are talking about how to stay motivated as a home poler. In this episode I talk about the most common motivation that men and women have for exercising, how home based exercise programs compare to center based programs, and how motivation can change depending on your age. I also talk through how to build self-efficacy as you are learning new skills on and off the pole. Whether you are new to pole or not, sometimes our motivation can change. Let's look together at the research behind it.  Sources: Al Kubaisy, W., Mohamad, M., Ismail, Z., & Abdullah, N. N. (2015). Gender Differences: Motivations for performing physical exercise among adults in Shah Alam. Procedia-Social and Behavioral Sciences, 202, 522-530. McDonagh, S. T., Dalal, H., Moore, S., Clark, C. E., Dean, S. G., Jolly, K., ... & Taylor, R. S. (2023). Home‐based versus centre‐based cardiac rehabilitation. Cochrane database of systematic reviews, (10). Schutzer KA, Graves BS. Barriers and motivations to exercise in older adults. Prev Med 2004;39:1056–61. Crystal N Steltenpohl, Michael Shuster, Eric Peist, Amber Pham, Joseph A Mikels, Me Time, or We Time? Age Differences in Motivation for Exercise, The Gerontologist, Volume 59, Issue 4, August 2019, Pages 709–717, https://doi.org/10.1093/geront/gny038 Al-Eisa, E., Al-Rushud, A., Alghadir, A., Anwer, S., Al-Harbi, B., Al-Sughaier, N., ... & Al-Muhaysin, H. A. (2016). Effect of motivation by “Instagram” on adherence to physical activity among female college students. BioMed research international, 2016(1), 1546013. This podcast is a production of Slink Through Strength, the inclusive, evidence-based online pole studio, which can be found online at Slink Through Strength dot com. Thanks for joining!

This is the Women of Influence Podcast series, delivering next level insights and expertise live from GlobeSt.'s Women of Influence Conference.The Women of Influence Podcast Series is an exclusive mini-series of The Crexi Podcast, an insider's look at all things commercial real estate, produced in collaboration with GlobeSt. The Crexi team visited Women of Influence and recorded in Lake Tahoe, California, from the floor of the conference, highlighting movers and shakers in commercial real estate. The Crexi Podcast explores various aspects of the commercial real estate industry in conversation with some of the top professionals in the space. In each episode, we feature different guests to tap into their wealth of CRE expertise and explore the latest trends and updates from the world of commercial real estate. In this episode, Crexi's Shanti Ryle sits with Julie Baird, President of First American Exchange Company, and Shayna Platt, Senior Director, ESG, at BioMed Realty, to cover wide-ranging topics, including:Introduction to the Crexi PodcastMeet Julie Baird: A Leader in Real EstateJulie's Career JourneyBuilding a Collaborative CultureChallenges and AchievementsMeeting People Where They AreCreating a Collaborative CultureAdvice for Young LeadersBuilding Trust and CollaborationChallenges and Opportunities for Women in LeadershipIndustry-Wide Efforts for DiversityConclusion and Contact InformationShayna Platt's Journey into ESGUniversity Influence and Early CareerRole at BioMed RealtyUnderstanding ESG in Commercial Real EstateChallenges in Implementing ESG PracticesGaining Internal Buy-In and EngagementPositive Outcomes and Executive SupportFuture Trends in Life Sciences Real EstateThe Importance of Accurate ESG DataAdvice for Young Professionals in ESGConnecting and Mentoring in ESGClosing RemarksAbout Julie Baird:Julie Baird is President of First American Exchange Company. She leverages people centered leadership practices to foster an organizational culture of collaboration, transparency, and trust, with employees reporting high job satisfaction while delivering record setting financial results.A fierce advocate for elevating female voices within the CRE industry, Julie has been a member of GlobeSt Woman of Influence speaking faculty since its inception and was awarded as a Woman of Influence in 2023; she was awarded First American's DPK Circle of Excellence Award in 2022, a recognition given to a very small number of the highest achieving employees in the entire organization of nearly 20,000 employees, and Julie was invited to participate in First American's Women in Leadership class of 2021 and selected by her class as a presenter to the First American Financial executive team.Julie is a past President of the Federation of Exchange Accommodators and is past Director for CREW Denver. She is a frequent speaker and author on 1031 exchange and industry related topics.Julie is a former Chair of the Executive Committee of the Real Property Law Section of the State Bar of California and she is the prior Managing Editor of the California Real Property Journal. In 2009, Julie was named as one of the "Top 20 Under 40" real estate professionals by the Commercial Real Estate Women (CREW) Network. Prior to joining First American, Julie was a real estate attorney in San Francisco.About Shayna Platt:Shayna Platt is the Senior Director of Environmental Social Governance (ESG) at BioMed Realty. A Blackstone Real Estate portfolio company, BioMed Realty is a leading provider of real estate solutions to the life science and technology industries. BioMed owns and operates high quality life science real estate comprising 15.9 million square feet concentrated in leading innovation markets throughout the United States and United Kingdom, including Boston/Cambridge, San Francisco, San Diego, Seattle, Boulder and Cambridge, U.K. In addition, BioMed maintains a premier development platform with 2.5 million square feet of Class A properties in active construction to meet the growing demand of the life science industry.About GlobeSt. Women of Influence: The Women of Influence Conference is an exclusive two-day event that celebrates the women who drive the commercial real estate industry forward. These influential leaders will discuss the critical issues facing CRE now and in the future, what it means to be a woman in business today and how women CRE leaders can uplift and support each other on their journey to the top.  If you enjoyed this episode, please subscribe to our newsletter and enjoy the next podcast delivered straight to your inbox. For show notes, past guests, and more CRE content, please check out Crexi's blog. Ready to find your next CRE property? Visit Crexi and immediately browse 500,000+ available commercial properties for sale and lease. Follow Crexi:https://www.crexi.com/​ https://www.crexi.com/instagram​ https://www.crexi.com/facebook​ https://www.crexi.com/twitter​ https://www.crexi.com/linkedin​ https://www.youtube.com/crexi

Pernah merasakan sakit kepala bagian belakang? Ternyata, hal ini bisa terjadi karena gejala penyakit tertentu atau kebiasaan buruk dalam beraktivitas. Lalu, bagaimana cara mengatasinya? Daripada bingung, yuk ke Konter Sehat! #KonterSehat #MitraKeluarga #sakitkepala #sarafkejepit #penyakitsaraf

Mainz BioMed CEO Guido Baechler joined Steve Darling from Proactive to announce the company has submitted an application to the U.S. Food and Drug Administration requesting Breakthrough Device Designation for its innovative non-invasive Next Generation colorectal cancer screening product. This product incorporates a novel portfolio of mRNA biomarkers. Achieving this designation could potentially expedite the approval process, significantly benefiting early cancer detection efforts. Baechler emphasized that the regulatory submission is backed by consistently strong results from the company's clinical studies, ColoFuture and eAArly Detect, as well as data from a comprehensive pooled study encompassing both the European and U.S. cohorts, which were presented at ASCO 2024. These studies have culminated in the final configuration of the Next Generation Test. This test integrates the Fecal Immunochemical Test with proprietary mRNA biomarkers and is enhanced by an advanced AI and machine learning algorithm. This integrated approach is set to be employed in the FDA premarket approval study. The Next Generation Test configuration was rigorously evaluated in a clinical setting involving 295 subjects from 21 specialized gastroenterology centers across the United States. The results underscored the exceptional efficacy of Mainz Biomed's multimodal screening test, which allows for precise differentiation among colorectal cancer, advanced adenomas, non-advanced adenomas, and samples with no pathological findings. The FDA's Breakthrough Devices Designation program is designed to accelerate the development, assessment, and review of medical devices and combination products that provide more effective treatment or diagnosis for life-threatening or irreversibly debilitating conditions. This designation for Mainz BioMed's colorectal cancer test could pave the way for quicker market access and wider availability of this critical diagnostic tool. #proactiveinvestors #mainzbiomednv #nasdaq #mynv #GuidoBaechler, #CancerScreening, #MolecularDiagnostics, #ColorectalCancer, #RNA, #Biomarkers, #PCRTechnology, #EarlyDetection, #CancerPrevention, #FecalBloodTest, #FDA, #BreakthroughDevice, #InnovativeHealth, #MedicalResearch, #DigestiveDiseaseWeek, #ASCO, #CancerResearch, #HealthTechnology, #PreventiveHealthcare #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

In episode 112, host Jon Wood speaks with Michele McKinley about the unique possibilities for partnership between the Biomedical and Sterile Processing departments. McKinley addresses how to build this relationship, the opportunities and challenges of collaboration, and how critical this interaction is when considering the best interests and protection of patients. Earn CE Now

Dr. Amicia Elliott always knew she wanted to be an entrepreneur. But on the path, she collected tools for her entrepreneur toolkit to get her to where she is today: PhD training, tech transfer, government research, postdoc fellowship. Now she is the Product Director with Form Bio. Hear about all the steps in her path on the last episode of Season 7. 

Dr. Justine Sinnaeve, PhD, is an Associate Scientific Director at Ashfield MedComms and tells us about her experience graduating during COVID and how she utilized that time to work freelance before launching into her SciComm/Medical Writing role. 

After a successful internship with Health Research in Action, Lindsay Redman Rivera used her experience to pivot to a full-time position. She discusses what she learned during her PhD training as well as shares her approach to the two-body-opportunity.

After a fellowship with the FDA in regulatory, Dr. Todd Townsend, PhD, shares his path to his current role as the Regional Medical Scientific Director, Cardiovascular & Metabolism at Merck. 

References Dr Guerra: membrane lectures Balin, M.1966. "Coming Back to Me" Jefferson Airplane. Surrealistic Pillow.1967. https://youtu.be/y2f3tlgApHw?si=cTa1nhYw6kcycxUs Dylan (Zimmerman),R. 1962 "Girl from the North Country". w. Johnny Cash. https://youtu.be/Je4Eg77YSSA?si=eYXfJhwOQisGjPHW Schubert, F. 1828.Piano Sonata in B-flat major, D.960 https://youtu.be/lncNcNtGkJY?si=KRTh3hQStQ3x51Ug --- Send in a voice message: https://podcasters.spotify.com/pod/show/dr-daniel-j-guerra/message Support this podcast: https://podcasters.spotify.com/pod/show/dr-daniel-j-guerra/support

References Biochimica et Biophysica Acta (BBA) - Biomembranes 2015. Volume 1848, Issue 3. Pages 805-812. J Immunol. 2018 Feb 1; 200(3): 915–927. Am J Rhinol Allergy. 2015 Jan-Feb; 29(1): 35–40. Corelli,A. 1714. Concerto in D Major Op. 6 No. 4, https://youtu.be/3smZkpqXYHs?si=uwEdDkRv-bz-zJXW --- Send in a voice message: https://podcasters.spotify.com/pod/show/dr-daniel-j-guerra/message Support this podcast: https://podcasters.spotify.com/pod/show/dr-daniel-j-guerra/support

References J Immunol. 2018 Feb 1; 200(3): 915–927 Cells. 2020 Jan; 9(1): 198. Cells. 2022 Apr; 11(7): 1105 Nature Comm. 2020. volume 11, Article number: 35 Schubert F. 1829. Fantasie in F minor. D940 https://youtu.be/UyjzqPPXDcw?si=XW_SMP7j-Kza8pmq Winwood, Capaldi and Wood. 1967 (Traffic). "Dear Mr Fantasy" https://youtu.be/dyMiUmrouZU?si=1ZSdXupm3WFBAxTz --- Send in a voice message: https://podcasters.spotify.com/pod/show/dr-daniel-j-guerra/message Support this podcast: https://podcasters.spotify.com/pod/show/dr-daniel-j-guerra/support

There is no typical day for co-founder and CEO of Infinimmune Wyatt McDonnell, PhD. Dive in to the whatnots and to-dos of starting and maintaining a company in this episode. 

References Clin Chim Acta . 2020 Sep:508:61-68 Applied Physiology, Nutrition, and Metabolism.2021. Volume 46, Number 8. --- Send in a voice message: https://podcasters.spotify.com/pod/show/dr-daniel-j-guerra/message Support this podcast: https://podcasters.spotify.com/pod/show/dr-daniel-j-guerra/support

The jump from academia to a start-up has been a fun one and we learn more as we sit down with Dr. Martin Moore, PhD, Chief Scientific Officer of Meissa Vaccines. 

In this episode of Medsider Radio, we had a riveting chat with David Hochman, founder and CEO of Orchestra BioMed, a company accelerating high-impact technologies through risk-reward-sharing partnerships with leading medical device companies.David has over two decades of experience in healthcare entrepreneurship, venture capital, and investment banking. He has a history of leading successful medical startups, including Orchestra Medical Ventures and Accelerated Technologies. As Chairman of Motus GI and former board member of Corbus Pharmaceuticals and PROLOR Biotech, David has been instrumental in advancing medical technologies, contributing to significant mergers & acquisitions, and many fundraising successes.In this interview he talks about driving successful partnerships, operational excellence in R&D, and the importance of a long-term strategy for sustainable industry innovation through aligned incentives. Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the recently launched Medsider Mentors Volume IV. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with David Hochman.

References Front. Immunol., 21 August 2019 Sec. Cancer Immunity and Immunotherapy Volume 10 Front Immunol. 2021; 12: 640869 PLoS One. 2014; 9(2): e87523 Vivaldi, A. 1719. "L 'inverno". https://youtu.be/pCqO-0339k0?si=k5xtuT8x7SfJeLok --- Send in a voice message: https://podcasters.spotify.com/pod/show/dr-daniel-j-guerra/message Support this podcast: https://podcasters.spotify.com/pod/show/dr-daniel-j-guerra/support

References Guerra-intermediary metabolic lecture archives ProcNatl Acad Sci U S A. 2014 Jun 17; 111(24): 8913–8918 Nutrition, Metabolism and Cardiovascular Diseases, 2023-09-01, Volume 33, Issue 9, Pages 1785-1796. Int J Cancer. 2019 Feb 1;144(3):533-544 --- Send in a voice message: https://podcasters.spotify.com/pod/show/dr-daniel-j-guerra/message Support this podcast: https://podcasters.spotify.com/pod/show/dr-daniel-j-guerra/support

What came first for Kristi Thiel: Co-Founder or Professor? Learn more about Dr. Thiel's interesting steps in her career path and all the great ideas that have helped her along the way. 

References Front Immunol. 2023; 14: 1151166 --- Send in a voice message: https://podcasters.spotify.com/pod/show/dr-daniel-j-guerra/message Support this podcast: https://podcasters.spotify.com/pod/show/dr-daniel-j-guerra/support

Bo and the crew talk about the chances LSU wins the SEC West, the big renovations to MRA and what NFL coaches look like they would do outside of the NFL in the third hour of the show live in the BankPlus Studio. The guys break down ways the SEC West could shake up with Alabama at the top and the possibility of Ole Miss beating Georgia still seems bleak. Head of School at Madison-Ridgeland Academy Termie Land joins the show talking about the big advancements with the Patriots. Termie talks about the recent AP Honor Roll Gold Distinction the school received and how hard it is to reach that standard. Termie talks about how MRA puts a huge emphasis on professional development and how the new Bio-Med program will help students grow. Bo and Termie talk about the newest and upcoming renovations for MRA and what to expect in the future. In the SEC Insider Hit, Bo and the crew talk about what NFL coaches look like they would do for work if they weren't coaching live in the BankPlus Studio. The guys look at some of the most well known coaches in the NFL and talk about how someone like Cowboys coach Mike McCarthy would be doing balloon animals at a kids birthday party. Bo looks at the young prodigy coaches like Mike McDaniel and Kyle Shanahan and how they have completely different looks. One of the most decorated coaches in the NFL isn't safe from the comparison and Bo thinks that Robert Saleh for the Jets looks like the perfect kickboxing instructor. Out of Bounds is sponsored by BetterHelp. Visit BetterHelp.com/BOUNDS today to get 10% off your first month Learn more about your ad choices. Visit megaphone.fm/adchoices

Head of School at Madison-Ridgeland Academy Termie Land joins the show talking about the big advancements with the Patriots. Termie talks about the recent AP Honor Roll Gold Distinction the school received and how hard it is to reach that standard. Termie talks about how MRA puts a huge emphasis on professional development and how the new Bio-Med program will help students grow. Bo and Termie talk about the newest and upcoming renovations for MRA and what to expect in the future. Out of Bounds is sponsored by BetterHelp. Visit BetterHelp.com/BOUNDS today to get 10% off your first month Learn more about your ad choices. Visit megaphone.fm/adchoices

The Sunday Times' tech correspondent Danny Fortson brings on Ranit Aharonov to talk about this moment for artificial intelligence (3:15), studying the brain (6:30), Project Debater (8:30), neural networks (11:30), language's AlphaGo moment (14:50), the big idea at Pangea (19:20), getting it into the hands of doctors and drug communities (23:25), the role of AI in this tool (26:15), the regulatory limits (32:15), and why she didn't debate the AI she created (37:25). Hosted on Acast. See acast.com/privacy for more information.

Overview Today is a different episode. I'm not talking to an author, this has to do with video games. Though it's not focused on video game storytelling as I've had in the past. It is related. I am talking with the coaches for the BioMed Science Academy eSports team. BioMed is a local alternative STEM school and they are one of over 200 schools in Ohio with eSports teams. This is important, because it shows the rise of videogames and how our culture is changing with that. Video games are still growing and there will be more future for today's kids to be in the video game industry - as storytellers or other. If you are a teacher or school administrator - this is a good episode to help introduce you to eSports. If you are a parent, there's a lot in here that you may not realize. I hope to do more episodes that deal with video games and video game storytelling. Website https://www.biomedscienceacademy.org/ YouTube https://youtu.be/_LRowafEIpU Transcription Stephen: Great. Okay. So today on Discover Wordsmiths, a very exciting conversation for me. If anyone's been following along on this podcast, I've had several interviews with some people in the video game industry where we talked about storytelling in video games. And today I'm continuing that with a couple of teachers at a local school, Biomed STEM Academy, which I'm very excited to talk to because they have an e sports team, one of the few in the area. So welcome Eric and Alexis. How are you guys doing? Eric: I'm doing wonderful. How Stephen: are you doing today? I'm I'm really doing great. I've been excited. I went to Blossom last night. So I went to bed late, but then all I could think about was talking to you guys. So if I yawn, I apologize. You're not boring. It's you know, body picking up. Before we start delving into this to inform parents and students or whatever tell us a little bit about biomed and what biomed is. Eric: So we're at biomed science Academy and biomed is a STEM plus M school. STEM stands for science, technology, engineering and mathematics. But we also have a medical pathway as well at our school. And what we do is instead of just teaching math, I will teach math in terms of different science and technology and engineering and even some of the health pathway. So the math that you see not only goes with the state's standards, but I'll also give those applications in the STEM field. And that's not just me, but the entire school that that's part of our mission and vision. Stephen: And my kids, after they went there, what I described that people is instead of just sitting down for a history class, where they tell you the Panama Canal was built at this time, they say, Go do a research on it and build us a working canal that you can move levers and adjust it and then tell us how it affected the economy in the area. And I'm like, Oh, my God, that tells you so much more than just it was built in this time. You know, about biomed. I remember the table of elements. You know, when I was in school, it's like, okay, memorize the table of elements. As much as you could. Who cares? Nobody, you can look it up. So who cares if you memorized it? But you guys put them in groups. Because that's important working in groups in the world and companies. And you said, okay, this is your one or two research. These tell us everything you, you can find out about it and give a report. And I guarantee those kids remembered those two better than everything else. And I always thought that was such a great approach to learning and more, much more exciting. I don't know if the students get it so much, but I would. So, all right. So what we're going to talk about a little bit more in depth today is your e sports team. And I was really excited about this because I've been trying to find out more about video game storytelling and it connected to e sports because Ohio just approved e sports teams in high scho...

TODAY ON THE ROBERT SCOTT BELL SHOW: Emord's Sacred Fire of Liberty, New Mexico governor outrage, Temporary Restraining Order Issued, Biden Impeachment Inquiry, Biden rambling in Vietnam, Ground Zero fact check, BioMed Expo, Toxic blood, Green cleaning warning, Mental health profits, Skin cancer options, Homeopathic Hit - Ignatia and MORE! http://www.robertscottbell.com/natural-remedies/emords-sacred-fire-of-liberty-new-mexico-governor-outrage-temporary-restraining-order-issued-biden-impeachment-inquiry-biden-rambling-in-vietnam-ground-zero-fact-check-biomed-expo-toxic-blood/

Tuvik Beker, CEO, and Ranit Aharonov, CTO of Pangea Biomed, have designed ENLIGHT, a computational platform driving precision oncology that matches cancer tumors with available therapies. Drawing on an understanding of synthetic mortality and synthetic rescue, this approach focuses on how the interaction between genes increases or decreases the tumor cell's fitness and the likely response to a drug. Determining which populations might benefit most from a drug opens the door to new treatments for common and rare diseases. Tuvik explains, "When we match therapies to patients, just according to the pure genetic characteristics of the tumor, sometimes we miss potential therapies, and sometimes we give patients therapies that do not work very effectively. To solve that, we developed ENLIGHT, which looks at the broader characteristics of the tumor, not just at the target gene, but multiple interactions, and that way, we can find potential therapies that are missed by the current guidelines and common biomarkers." Ranit elaborates, "So when we search for these interactions between genes, we look at a lot of available cancer data. We have a large database of a lot of cell lines that were treated and human tumors, and we know the survival of the patients and so on, but we don't need to know anything about what drugs they got. Our algorithms allow us, by looking at a lot of correlations between different activations of genes and survival and what happens to cells, we are able to find what are the pairs in the entire genome of genes that their co-activation affects the fitness or the tumor survival. And by knowing this, you can think of it as a sort of vulnerability map of tumors." "One of the things I haven't yet described and I think wouldn't have happened without this revolution is that we can now move a step further. When we look at a patient's tumor, we don't necessarily need to measure the RNA expression or the activation of genes directly. We can look at the tumor through a microscope using standard histopathology slides, the ones with the bluish and pinkish coloring that have been used for decades and are really available everywhere." #PrecisionsMedicine #Oncology #PrecisionOncology #RareDisease #Biotech #Startup #AI #MachineLearning pangeabiomed.com Listen to the podcast here

Tuvik Beker, CEO, and Ranit Aharonov, CTO of Pangea Biomed, have designed ENLIGHT, a computational platform driving precision oncology that matches cancer tumors with available therapies. Drawing on an understanding of synthetic mortality and synthetic rescue, this approach focuses on how the interaction between genes increases or decreases the tumor cell's fitness and the likely response to a drug. Determining which populations might benefit most from a drug opens the door to new treatments for common and rare diseases. Tuvik explains, "When we match therapies to patients, just according to the pure genetic characteristics of the tumor, sometimes we miss potential therapies, and sometimes we give patients therapies that do not work very effectively. To solve that, we developed ENLIGHT, which looks at the broader characteristics of the tumor, not just at the target gene, but multiple interactions, and that way, we can find potential therapies that are missed by the current guidelines and common biomarkers." Ranit elaborates, "So when we search for these interactions between genes, we look at a lot of available cancer data. We have a large database of a lot of cell lines that were treated and human tumors, and we know the survival of the patients and so on, but we don't need to know anything about what drugs they got. Our algorithms allow us, by looking at a lot of correlations between different activations of genes and survival and what happens to cells, we are able to find what are the pairs in the entire genome of genes that their co-activation affects the fitness or the tumor survival. And by knowing this, you can think of it as a sort of vulnerability map of tumors." "One of the things I haven't yet described and I think wouldn't have happened without this revolution is that we can now move a step further. When we look at a patient's tumor, we don't necessarily need to measure the RNA expression or the activation of genes directly. We can look at the tumor through a microscope using standard histopathology slides, the ones with the bluish and pinkish coloring that have been used for decades and are really available everywhere." #PrecisionsMedicine #Oncology #PrecisionOncology #RareDisease #Biotech #Startup #AI #MachineLearning pangeabiomed.com Download the transcript here

For this episode, I was joined by Brian DeHaven, PhD, inaugural chief program director for the College's Biomedical Sciences program. Dr. DeHaven joined PCOM earlier this year and has an ambitious agenda for the BioMed program. He and I discuss his vision for the program and what sets PCOM apart from its peers; changes to education as a result of the pandemic and the effort to meet students where they are; and the future of graduate medical education.

The FDA warns of a vulnerability affecting biomedical devices. Ransomware's effects continue to trouble the US Marshals Service. The US Justice Department shifts how it deals with large scale cybercrime. Fresh phish from the GRU. Caleb Barlow looks at unicorns and zombiecorns. Our guest Manoj Sharma from Symantec explains the differences between Zero Trust and SASE. And KillNet runs an ask-me-anything session. For links to all of today's stories check out our CyberWire daily news briefing: https://thecyberwire.com/newsletters/daily-briefing/12/83 Selected reading. Illumina cyber vulnerability may present risks for patient results (U.S. Food and Drug Administration) CISA, FDA warn of new Illumina DNA device vulnerability (Record Key law enforcement computers still down 10 weeks after breach (Washington Post) Feds Prioritizing Disruptions Over Arrests in Cyberattack Cases (PCMAG)  "Ashamed" LockBit ransomware gang apologises to hacked school, offers free decryption tool (Hot for Security)  APT28 cyberattack: distribution of emails with "instructions" on "updating the operating system" (CERT-UA#6562) (CERT-UA) Hackers use fake ‘Windows Update' guides to target Ukrainian govt (BleepingComputer)  Ukraine at D+431: Drone strikes and phishing expeditions. (CyberWire)

Character Database: Biomedical EngineerAmanda Randles is a computer scientist who is the Alfred Winborne and Victoria Stover Mordecai Professor of Biomedical Sciences at Duke University. Randles has been an assistant professor of biomedical engineering and computer science at the university and works at the Duke Cancer Institute. Her research includes biomedical simulation and high-performance computing.For the full uncut video (36mins) and access to our entire character database become a Monthly or Pro member at The Successful Screenwriter.--> https://www.thesuccessfulscreenwriter.com

Dr. Cara Lang, PhD, is a Disease Area Analyst of Ovarian Cancer with Oncology Resource Group. In this episode, Dr. Lang shares her insight into her role and how she made the decisions around her post-grad next step, as well as the opportunities that best prepared her for this position.

In this podcast we'll talk with Chris Hartman, president, epilepsy, LivaNova, about how the company is developing new tools to use the vagus nerve to limit the impact of epilepsy. We'll also hear from one of our DeviceTalks West Panels about how workforce shortages are impacting medical device development. The panelists are Nilesh Patel, M.D. Vice President, Medical Affairs, Neuromodulation, Boston Scientific; Farzad Azimpour, M.D. Senior Vice President, Strategic Innovation, Edwards Lifesciences; and Nick West, M.D. Chief Medical Officer, Divisional Vice President, Medical Affairs, Vascular, Abbott. Executive Editor Chris Newmarker deliveres his Newmarker's Newsmakers – highlighting news from Butterfly Networks, Dentsply Sirona, Stryker, Titan Medical, Johnson & Johnson and Biomed. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to this podcast on all major podcast players.

When Dr. Holly was first diagnosed with breast cancer, she was pretty underwhelmed with her care.When Dr. Holly was first diagnosed with breast cancer, she was pretty underwhelmed with her care. Cancer is a complex disease, and she thought there was more she could do to help her body than just take pills. It was then she remembered the work fof today's guest (who has been on the podcast before!) and called her up. Jess Higgins Kelley MNT, ONC is a Master Nutrition Therapist, Oncology Nutrition Consultant, teacher, writer, and nutrition education program developer. An Oncology Nutrition Consultant for over a decade, Jess has extensive experience working with cancer and chronic illness clients from around the globe. She is also the co-author of two books, The Metabolic Approach to Cancer: Integrating Deep Nutrition, the Ketogenic Diet, and Nontoxic Bio-Individualized Therapies, and Bioregulatory Medicine: An Innovative Holistic Approach to Self-Healing.Jess is the Founder and Director of the Oncology Nutrition Institute which provides online certification programs for professionals and education for the public in therapeutic metabolic nutrition. An avid researcher and student, Jess has completed certifications in Environmental Medicine through the University of Arizona Medical School, Nutrigenomics through Nutrition Genome, Endocrinology and Blood Chemistry Analysis through Apex Energetics, Scientific Phytotherapy through alchemlife, and Methylation and Clinical Nutrigenomics through Bastyr University. Jess was an instructor at the Nutrition Therapy Institute in Denver, Colorado from 2011-2017, and believes strongly in empowerment through education.The Oncology Nutrition Institute believes that holistic, therapeutic, metabolic nutrition should be part of the standard of care. The world needs more qualified practitioners to help support clients/patients improve quality and quantity of life using dietary therapies, nutrition interventions, and lifestyle modifications. This continuing education certification program will not only enhance your practice, it also encourages students to focus on their own health. Reducing future cancer risk starts with what we eat today.Jess's Cancer book:  http://bit.ly/MetabolicApproach  Jess's BioMed book: https://amzn.to/2Gv8xcY

This is the 3rd episode in the Cancer Series. In this episode, you'll hear a bit about precision medicine in oncology, drug repurposing and the increasing challenges precision medicine poses for clinical trials. I spoke with Tuvik Beker, CEO of Pangea Biomed, an Israeli-based company tackling oncology drug development and treatment recommendation by not only looking at the single mutations in tumor cells, which the Pharmaceutical industry has already found targeted therapies for. Cancer treatments are evolving very rapidly, but precision and targeted therapies are still only effective in roughly 10% of cancer patients. Pangea Biomed tries to understand broader gene activation patterns inside tumor cells and recommends a therapy that would help exploit cancer cells' defense mechanisms.  As explained in simplified terms by Tuvik Beker. Cancer Series Ep. 1: Access to Care, Financial Toxicity and Healthcare IT in Oncology Speaker: David J. Stewart, MD, FRCPC, Professor of Medicine in the Division of Medical Oncology at the University of Ottawa and The Ottawa Hospital.  Cancer Series Ep.2: Cancer, Genomics and Data Science Speaker: Xose M. Fernandez, genomicist and up until recently the Chief Data Officer at Institut Curie in France, one of the leading medical, biological, and biophysical research centers in the world.   SUBSCRIBE TO THE MONTHLY NEWSLETTER: https://fodh.substack.com/ www.facesofdigitalhealth.com Leave a rating or a review: lovethepodcast.com/facesofdigitalhealth Thank you! :)

This podcast episode is relevant to every autism mom out there. It's also a survival story.She shares the nutritional imbalances (now regulated) and biochemical challenges with you and your child. How she dealt with compulsive OCD, self-harm, binge eating and eating disorders, food OCD, anxiety, depression and obsessions is how you need to address these issues. It's a story about overcoming binge eating, diet OCD, anxiety, self-harm & suicidal thoughts. Experienced by someone who shares chemistry and nutritional imbalances with 90 % of autism moms and autistic children who learned how to regulate their biochemistry with food THE HARD WAY. Samatha Gilbert is an incredible woman, colleague and autism nutritionist. Dr Mensah saved her life after she's been considering ending it on Golden Gate Bridge several times after a long life of self-harm, anxiety, restrictive eating, binge eating, veganism (that made her feel worse) and depression. When she learned what undermethylation, pyrrole disorder, copper toxicity and a superfood/vegetable-based GF/DF diet did to her mental health and how she could eat herself well - she dedicated her life to helping families with children/young people with similar problems with her Eat For Life strategy. It wasn't that she wasn't health-focused or knowledgeable. Just like you - she was already an expert in functional medicine and holistic health. She was (like many autism moms who focus on recovery and Biomed) - from an outsider's perspective - extremely healthy. The problem with healthy eating, dieting and holistic health today is that it's making a massive group of people (especially autism families) WORSE. In this podcast, you'll learn: How body dysmorphia and binge eating on cupcakes started at age five for Samantha and why you need to understand the link to undermethylation and copper metabolism early and catch it.How untreated biochemical and nutritional imbalances escalated into starvation & binge eating, OCD, anxiety, extreme veganism and depression/suicidal thoughts and why it is something you MUST prevent for your child. The link between disordered eating (including picky eating), undermethylation, serotonin and dopamine. Non-purging extreme self-punishment (over-exercise and fasting and the consequences of that. Treating mental health issues should have a nutritional approach instead of solely focusing on the brain/behaviour/cognition and emotional therapy. It doesn't work. How Samantha lost her hearing at the well visit after getting the "you know what" at 15 months. Why autism families NEED MEAT in their diet to heal and thrive. Why getting healthy sometimes means gaining weight in the healing process. Especially if you've been dieting for years. The problem with folate/folic acid. How copper can drive someone to the edge and suicidal tendencies.Why "Root cause protocol" is a dangerous and harmful health trend in the autism recovery community. And so much more...

This week's guest is Tim Schoen, President and CEO of BioMed Realty, a Blackstone company and an industry leader in life science and technology-focused real estate. Tim is a deeply experienced real estate and capital markets professional, and he is a true business leader within the biotech field.

This week's guest is Tim Schoen, President and CEO of BioMed Realty, a Blackstone company and an industry leader in life science and technology-focused real estate. Tim is a deeply experienced real estate and capital markets professional, and he is a true business leader within the biotech field. In this episode, Tim drills into the dynamics of the biotech real estate space, which has such a different business model, unique customer base, and range of specialty skills within the team to make it a market leader.Tim shares his passion about the real estate business overall as well as the intellectual engagement in focusing on the biotech field. Tim is fascinating to listen to because he is “always learning,” as evidenced by his leadership at BioMed, serving on the Salk Institute Board, and the challenges and opportunities for both the bio tech and real estate businesses to contribute to carbon reduction. ResourcesBioMed Realty

Listen on Apple, Google, Spotify, and other platforms. Maritza gives an overview of what ITJuana is [03:02] Maritza talks about the earlier perception of Tijuana, and the successful experiment they did of hiring engineers in Tijuana. [04:31] Maritza shares her objective in life and why ITJuana veer from traditional outsourcing [07:05] Maritza talks about the transformation that happened to their company when the pandemic happened, and the tech talents from Latin America [09:57] Maritza shares how ITJuana has been focusing and investing time and effort in talent development [11:52] What does Maritza perceive as the local tech community now? [14:46] Maritza shares the opportunities that have opened for talents in Tijuana and her goal of Tijuana becoming the "BioMed tech valley" of the world[16:31] Maritza gives advice to people who are thinking about building a startup or investing in a company like ITJuana [18:00] Maritza shares some tips and tricks she learned to grow her business [19:01] Maritza talks about the manufacturing in Tijuana [21:43] Maritza shares her favorite taco spots, Taco Nazo, Telefonica, and Valle de Guadalupe [24:18]    Follow Maritza online LinkedIn   ITJuana Website | LinkedIn | Facebook | Twitter

I want you to meet TWO new moms that recently came into my community. I know that they have so much to share that you can learn from to make your autism turnaround journey easier (and maybe even quicker).I've wanted to sit down with two moms who are at the BEGINNING of the autism turnaround journey with their children for the longest time. That dream came true in this episode of the Barefoot autism warriors podcast. -I wanted a roundtable discussion with new autism moms who are new to the recovery/autism turnaround journey in Barefoot Autism Warriors. I normally interview moms at the end of their journey (testimonials). I wanted to bring relatable tips from beginners (new autism moms in my community). I figured that it would be more relatable for younger autism moms who're still struggling with tantrums, regression, nonverbal autism, eloping, sleepless nights and screaming to hear from moms who've just been there and know what you can do to change this (because they literally just did (and still are working on it.)  Little did I know that I was about to get the secret from these two mothers about how to speed up the recovery process without focusing on the child, chasing cures, tests, autism diets and Biomed. In this podcast episode with Ninka-Bernadette Mauritson's guests  Stacia (USA) and Gro (Scandinavia) you'll get so many insights and tips about autism recovery, leaving expensive biomedical treatments, autism mom stress and what works to overcome autism symptoms. In this episode, we cover: StaciaHow to go from eloping, collapsing on the floor (because of sleep deprivation) and having nonverbal autism to having a helpful child who's calm and able to have great conversations with his family now. What it feels like to be so stressed out and tired that you collapse on the floor and jump if your husband touches your shoulder.She feared that this would be forever and that her child would never become independent. How that's changed and why. The biomedical roller-coaster (ups that always led to disappointing downs and money wasted). God's guidance. The point of no return was when her husband ended the money spent on biomedical treatments  10 - 20.000 $ that didn't work, and what happened next...How she felt when she could not take her children to the shop or go on family trips together because of dangerous autism symptoms? How God led her in a completely different direction and what a certain podcast with Luke Storey had to do with getting closer to real results. Gro: Having child number two right after child number 1 was diagnosed (and how she dealt with both of them being autistic. Being a single autism mom of 2 and surviving the stress of having two children with autism.Self-sabotage and addiction to stress and cortisol. How it felt to be so stressed that you didn't want to be on earth anymore. The autism-mom PTSD that almost destroyed her. Looking for solutions in New Age spirituality before realizing how dark and deceptive that was (and turning to God instead.) Finding peace and getting her children to a better place and the AMAZING changes she's now experiencing (that you can copy). What these mothers shared was much more than I'd hoped for. Even though these two moms are in the thick of it and just recently started working with me - the changes they've seen are INCREDIBLE. Ps: I'm starting a coaching group for new autism moms Sep 1. We're going to focus on turning autism symptoms around. Would you like to join us?  Email us here